These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 39209097)
1. Targeting Skp2 degradation with troxerutin decreases neointima formation. Liu X; Chai R; Xu Q; Zou M; Jiang S; Liu Y; Li R; Kong T; Chen X; Xu R; Liu S; Zhang Z; Liu N Eur J Pharmacol; 2024 Nov; 982():176947. PubMed ID: 39209097 [TBL] [Abstract][Full Text] [Related]
2. 3,3'Diindolylmethane suppresses vascular smooth muscle cell phenotypic modulation and inhibits neointima formation after carotid injury. Guan H; Zhu L; Fu M; Yang D; Tian S; Guo Y; Cui C; Wang L; Jiang H PLoS One; 2012; 7(4):e34957. PubMed ID: 22506059 [TBL] [Abstract][Full Text] [Related]
3. USP10 exacerbates neointima formation by stabilizing Skp2 protein in vascular smooth muscle cells. Xia X; Liu X; Chai R; Xu Q; Luo Z; Gu J; Jin Y; Hu T; Yu C; Du B; Huang H; Ou W; Liu S; Liu N J Biol Chem; 2021 Nov; 297(5):101258. PubMed ID: 34599966 [TBL] [Abstract][Full Text] [Related]
4. c-myc and skp2 coordinate p27 degradation, vascular smooth muscle proliferation, and neointima formation induced by the parathyroid hormone-related protein. Sicari BM; Troxell R; Salim F; Tanwir M; Takane KK; Fiaschi-Taesch N Endocrinology; 2012 Feb; 153(2):861-72. PubMed ID: 22210745 [TBL] [Abstract][Full Text] [Related]
5. Adipose differentiation‑related protein knockdown inhibits vascular smooth muscle cell proliferation and migration and attenuates neointima formation. Zhao H; Han T; Hong X; Sun D Mol Med Rep; 2017 Sep; 16(3):3079-3086. PubMed ID: 28713961 [TBL] [Abstract][Full Text] [Related]
6. Targeting AGGF1 (angiogenic factor with G patch and FHA domains 1) for Blocking Neointimal Formation After Vascular Injury. Yao Y; Hu Z; Ye J; Hu C; Song Q; Da X; Yu Y; Li H; Xu C; Chen Q; Wang QK J Am Heart Assoc; 2017 Jun; 6(6):. PubMed ID: 28649088 [TBL] [Abstract][Full Text] [Related]
7. Digoxin inhibits PDGF-BB-induced VSMC proliferation and migration through an increase in ILK signaling and attenuates neointima formation following carotid injury. Yan G; Wang Q; Hu S; Wang D; Qiao Y; Ma G; Tang C; Gu Y Int J Mol Med; 2015 Oct; 36(4):1001-11. PubMed ID: 26311435 [TBL] [Abstract][Full Text] [Related]
9. Formononetin protects against balloon injury‑induced neointima formation in rats by regulating proliferation and migration of vascular smooth muscle cells via the TGF‑β1/Smad3 signaling pathway. Song T; Zhao J; Jiang T; Jin X; Li Y; Liu X Int J Mol Med; 2018 Oct; 42(4):2155-2162. PubMed ID: 30066831 [TBL] [Abstract][Full Text] [Related]
10. S-phase kinase-associated protein-2 (Skp2) promotes vascular smooth muscle cell proliferation and neointima formation in vivo. Wu YJ; Sala-Newby GB; Shu KT; Yeh HI; Nakayama KI; Nakayama K; Newby AC; Bond M J Vasc Surg; 2009 Nov; 50(5):1135-42. PubMed ID: 19878790 [TBL] [Abstract][Full Text] [Related]
20. Soluble epoxide hydrolase is involved in the development of atherosclerosis and arterial neointima formation by regulating smooth muscle cell migration. Wang Q; Huo L; He J; Ding W; Su H; Tian D; Welch C; Hammock BD; Ai D; Zhu Y Am J Physiol Heart Circ Physiol; 2015 Dec; 309(11):H1894-903. PubMed ID: 26453326 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]